Cases & Deals

  • Home
  • Practices
  • Ambit Biosciences develops patent portfolio for small molecule kinase inhibitor programs

Share

Ambit Biosciences develops patent portfolio for small molecule kinase inhibitor programs

January 2007

Client(s) Ambit Biosciences

Jones Day represented Ambit Biosciences in the development of patent portfolios related to small molecule kinase inhibitor programs and phage-displayed protein assays.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.